PAPER De Kort AM, Kaushik K, Kuiperij HB, Jäkel L, Li H, Tuladhar AM, Terwindt GM, Wermer MJ, Claassen JA, Klijn CJ, Verbeek MM, Kessels RP, Schreuder FH

The relation of a cerebrospinal fluid profile associated with Alzheimer's disease with cognitive function and neuropsychiatric symptoms in sporadic cerebral amyloid angiopathy.

Alzheimers Res Ther. 2024 May 4;16(1):99. PubMed: 38704569

PAPER Thumbadoo KM, Dieriks BV, Murray HC, Swanson ME, Yoo JH, Mehrabi NF, Turner C, Dragunow M, Faull RL, Curtis MA, Siddique T, Shaw CE, Newell KL, Henden L, Williams KL, Nicholson GA, Scotter EL

Hippocampal aggregation signatures of pathogenic UBQLN2 in amyotrophic lateral sclerosis and frontotemporal dementia.

Brain. 2024 May 4; PubMed: 38703371

PAPER Ilieva NM, Hoffman EK, Ghalib MA, Greenamyre JT, De Miranda BR

LRRK2 kinase inhibition protects against Parkinson's disease-associated environmental toxicants.

Neurobiol Dis. 2024 May 3;:106522. PubMed: 38705492

PAPER Vaidya B, Gupta P, Biswas S, Laha JK, Roy I, Sharma SS

Effect of Clemizole on Alpha-Synuclein-Preformed Fibrils-Induced Parkinson's Disease Pathology: A Pharmacological Investigation.

Neuromolecular Med. 2024 May 4;26(1):19. PubMed: 38703217

PAPER Ashendorf L, Withrow S, Gavett BE

The Neuropsychological Assessment Battery Driving Scenes Test in a Dementia Clinic.

Arch Clin Neuropsychol. 2024 May 4; PubMed: 38704735

PAPER Chen Y, Xu R, Liu Q, Zeng Y, Chen W, Liu Y, Cao Y, Liu G, Chen Y

Rosmarinic acid ameliorated oxidative stress, neuronal injuries, and mitochondrial dysfunctions mediated by polyglutamine and ɑ-synuclein in Caenorhabditis elegans models.

Mol Neurobiol. 2024 May 4; PubMed: 38703342

PAPER Chen Y, Zhang W, Li Q, Xie H, Xing S, Lu X, Lyu W, Xiong B, Wang Y, Qu W, Liu W, Chi H, Zhang X, Feng F, Sun H

Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of Alzheimer's disease.

Eur J Med Chem. 2024 Apr 30;272:116463. PubMed: 38704944

PAPER Wang Z, Wang R, Niu L, Zhou X, Han J, Li K

EPB41L4A-AS1 is required to maintain basal autophagy to modulates Aβ clearance.

NPJ Aging. 2024 May 4;10(1):24. PubMed: 38704365

PAPER Masato A, Bubacco L

The αSynuclein half-life conundrum.

Neurobiol Dis. 2024 May 3;:106524. PubMed: 38705490

PAPER Lu J, Zhang J, Wang X, Yuan F, Xin B, Li J, Yang Q, Li X, Zhang J, Wang X, Fu J, Guo C

Dl-3-n-butylphthalide promotes microglial phagocytosis and inhibits microglial inflammation via regulating AGE-RAGE pathway in APP/PS1 mice.

Brain Res Bull. 2024 May 3;:110969. PubMed: 38705540

PAPER Conca F, Esposito V, Catricalà E, Manenti R, L'Abbate F, Quaranta D, Giuffrè GM, Rossetto F, Solca F, Orso B, Inguscio E, Crepaldi V, De Matteis M, Rotondo E, Manera M, Caruso G, Catania V, Canu E, Rundo F, Cotta Ramusino M, Filippi M, Fundarò C, Piras F, Arighi A, Tiraboschi P, Stanzani Maserati M, Pardini M, Poletti B, Silani V, Marra C, Di Tella S, Cotelli M, Lodi R, Tagliavini F, Cappa SF

Clinical validity of the Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB) in Mild Cognitive Impairment and Alzheimer's Disease.

Alzheimers Res Ther. 2024 May 4;16(1):98. PubMed: 38704608

PAPER Wang M, Lu J, Zhang Y, Zhang Q, Wang L, Wu P, Brendel M, Rominger A, Shi K, Zhao Q, Jiang J, Zuo C

Characterization of tau propagation pattern and cascading hypometabolism from functional connectivity in Alzheimer's disease.

Hum Brain Mapp. 2024 May;45(7):e26689. PubMed: 38703095

PAPER Haidar M, Schmid B, Ruiz A, Ebneth A, Cabrera-Socorro A

Generation of three isogenic, gene-edited iPSC lines carrying the APOE-Christchurch mutation into the three common APOE variants: APOE2Ch, APOE3Ch and APOE4Ch.

Stem Cell Res. 2024 Apr 6;77:103414. PubMed: 38703665

PAPER Zeissler ML, Bakshi N, Bartlett M, Batla A, Byrom D, Chapman R, Collins S, Cowd E, Deeson E, Ellis-Doyle R, Forbes J, Gonzalez-Robles C, Jewell A, Lane EL, LaPelle NR, Martin K, Matthews H, Miller L, Mills G, Morgan A, Parry M, Pushparatnam K, Ratcliffe N, Salathiel D, Scurfield P, Siu C, Whipps S, Wonnacott S, Foltynie T, Carroll CB, McFarthing K, EJS ACT-PD consortium

Patient and Public Involvement and Engagement in the Development of a Platform Clinical Trial for Parkinson's Disease: An Evaluation Protocol.

J Parkinsons Dis. 2024 Apr 27; PubMed: 38701161

PAPER Gong HS, Pan JP, Guo F, Wu MM, Dong L, Li Y, Rong WF

Sodium oligomannate activates the enteroendocrine-vagal afferent pathways in APP/PS1 mice.

Acta Pharmacol Sin. 2024 May 3; PubMed: 38702501